Allergy Treatment Market

Allergy Treatment Market (Allergy Type: Food Allergy, Inhaled Allergy, Drug Allergy, and Others; and Treatment: Anti-allergy Drugs and Immunotherapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2034

Allergy Treatment Market Outlook 2034

  • The global industry was valued at US$ 18.9 Bn in 2023
  • It is estimated to grow at a CAGR of 5.8% from 2024 to 2034 and reach US$ 34.9 Bn by the end of 2034

Analyst Viewpoint

Increase in incidence of allergies caused due to exposure to certain foods, pollens, dusts, and mites is a leading contributor to the allergy treatment market growth. Erratic lifestyles, pre-existing genetic conditions, and climate change are factors leading to a surge in cases of allergies.

Constant innovations in allergy therapeutics, led by investments in diagnostic tools and preventive measures, is also boosting the allergy treatment market size. Prevalence of asthma and food allergies is a major cause of concern.

It is leading to the development of tablets, drops, and other safe methods of symptom relief and allergy prevention. Leading market players are acquiring smaller firms and building close relationship with each other to remain competitive in the highly lucrative sector.

Allergy Treatment Market Overview

Allergy treatment is a term used to refer to several interventions or approaches designed to mitigate allergic reactions triggered by exposure to allergens such as certain foods, mites, dust, and pollens.

These therapeutics are applied in hospitals, primary care facilities, pediatric centers, and general clinics to treat a wide range of conditions such as food allergies, asthma, eczema, and allergic rhinitis.

Allergic condition therapy primarily relieves symptoms of severe allergies such as nasal congestion, hives, wheezing, itching, and sneezing that can significantly degrade the quality of life of the individual.

Advantages of such therapeutics include prevention of severe allergic reactions, management of long-term conditions, enhanced quality of life, and short-term symptom relief.

Recent allergy treatment market trends suggest a growth in focus on patient compliance and efficiency. Innovations in immunotherapy for allergies include techniques such as sublingual immunotherapy (SLIT) and subcutaneous immunotherapy (EPIT).

Developments in personalized medicine and natural remedies improve drug formulations, diagnosis, and treatment.

Attribute Detail
Market Drivers
  • Increase in Prevalence of Allergies
  • Advancements in Allergy Management

Rise in Prevalence of Allergies Fueling Market Progress

Adoption of erratic lifestyle, environmental degradation, and pre-existing genetic predispositions are primary contributors to the rise in incidence of allergies, thereby boosting allergy treatment market opportunities.

Surge in number of people diagnosed with severe cases of allergies is augmenting the demand for effective treatment options. This is prompting pharmaceutical firms to invest continuously in research and development of advanced methods, diagnostic tools, and preventive measures.

According to the Global Allergy and Airways Patient Platform, there has been an increase in cases of allergic conditions and severe reactions, with an estimated 30% to 40% of the world population suffering from one or more allergic conditions.

According to data published by WebMD, seasonal allergies cost the U.S. healthcare system and businesses about U.S. 20 Bn annually in expenditure, treatment, and lost productivity.

Advancements in Allergy Management Bolstering Allergy Treatment Industry Growth

Innovations in hypersensitivity relief and allergy therapeutics focus on enhanced patient convenience, safety, and treatment efficacy.

Integration of biologic therapies to target specific pathways that cause allergic reactions, application of advanced drug delivery pathways, and individualized approaches to cater to diverse reactions have been gaining traction of late.

Surge in cases of asthma and allergic rhinitis among children and pre-teens is leading to a rise in investments in allergy medication and symptom relief methods such as sublingual tablets or drops, as they are easy to administer and offer enhanced safety.

Development of allergy-friendly foods for children and natural remedies for pollen reactions are propelling allergy treatment market statistics.

According to the National Institute of Allergy and Infectious Diseases (NIAID), the cost per patient for treatment of severe asthma can amount to nearly US$ 3300. The institution also offers several grants and contracts for research and development of anti-allergic injections and antibiotic resistance.

Regional Outlook

Attribute Detail
Leading Region North America

North America accounted for the largest allergy treatment market share in 2023. Increase in spending in pharmaceutical research, growth in awareness about food allergies, and presence of advanced healthcare infrastructure are fueling the market dynamics of the region.

According to Food Allergy and Research Education, about 32 million people in the U.S. have food allergies. Shellfish allergies and dairy product related allergies are the most common in the country.

As per the latest allergy treatment market forecast, the industry in Asia Pacific is projected to grow at a steady pace during the period between 2024 and 2034. Spur in population, rise in adoption of unhealthy diet, and growth in access to medical care are factors fostering market development in the region.

Analysis of Key Players

Leading firms in the global allergy treatment market are investing substantially in development of holistic allergy treatment options in order to cater to the growing demand from younger demographics as awareness around allergies and therapeutics improves.

Close collaborations with other companies, outsourcing, and regional expansion enable entities in the allergy treatment industry to expand their product portfolio. Merger & acquisition is one of the vital strategies adopted by the leading players to maintain their dominance in an evolving landscape.

ALK, Stallergenes Greer, Allergy Therapeutics, HAL Allergy B.V., GSK, Sunovion Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Thermo Fisher Scientific, Inc., and Meda AB are prominent firms operating in this sector.

The allergy treatment market report focuses on parameters such as company overview, financial overview, product portfolio, business strategies, and business segments of the companies mentioned above.

Key Developments

  • In February 2024, Genentech, a prominent pharmaceutical company, announced that its novel anti-allergy injection called Xolair had received U.S. Food and Drug Administration (FDA) approval for severe allergy treatment caused by exposure to certain food. The drug has been approved for usage in adults and children above the age of one.

Allergy Treatment Market Snapshot

Attribute Detail
Market Value in 2023 (Base Year) US$ 18.9 Bn
Market Forecast Value in 2034 US$ 34.9 Bn
Growth Rate (CAGR) 5.8%
Forecast Period 2024-2034
Historical Data Available for 2020-2022
Quantitative Units US$ Bn for Value
Market Analysis The qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis.
Competition Landscape
  • Prominent Players - Competition Dashboard and Revenue Share Analysis, 2023
  • Company Profiles (Details - Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
Format Electronic (PDF) + Excel
Market Segmentation
  • Allergy Type
    • Food Allergy
    • Inhaled Allergy
    • Drug Allergy
    • Others
  • Treatment
    • Anti-allergy Drugs
    • Immunotherapy
      • Subcutaneous Immunotherapy (SCIT)
      • Sublingual Immunotherapy (SLIT)
  • Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies & Drug Stores
    • Online Pharmacies
Regions Covered
  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • U.K.
  • France
  • Spain
  • Germany
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • Israel
  • South Africa
Companies Profiled
  • ALK
  • Stallergenes Greer
  • Allergy Therapeutics
  • HAL Allergy B.V
  • GSK
  • Sunovion Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Thermo Fisher Scientific, Inc.
  • Meda AB
Customization Scope Available upon Request
Pricing Available upon Request

Frequently Asked Questions

How big was the global allergy treatment market in 2023?

It was valued at US$ 18.9 Bn in 2023

How is the allergy treatment business expected to grow by 2034?

It is projected to grow at a CAGR of 5.8% from 2024 to 2034

What are the key factors driving the demand for allergy treatment?

Increase in prevalence of allergies and advancements in allergy management

Which was the major region in the global allergy treatment industry in 2023?

North America dominated the global landscape in 2023

Who are the key allergy treatment drugs manufacturers?

ALK, Stallergenes Greer, Allergy Therapeutics, HAL Allergy B.V, GSK, Sunovion Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Thermo Fisher Scientific, Inc., and Meda AB

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Allergy Treatment Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Allergy Treatment Market Analysis and Forecast, 2020-2034

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product /Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. Global Allergy Treatment Market Analysis and Forecast, by Allergy Type

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Allergy Type, 2020-2034

        6.3.1. Food Allergy

        6.3.2. Inhaled Allergy

        6.3.3. Drug Allergy

        6.3.4. Others

    6.4. Market Attractiveness Analysis, by Allergy Type

7. Global Allergy Treatment Market Analysis and Forecast, by Treatment

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Treatment, 2020-2034

        7.3.1. Anti-allergy Drugs

            7.3.1.1. Antihistamines

            7.3.1.2. Corticosteroids

            7.3.1.3. Leukotriene Inhibitors

            7.3.1.4. Others

        7.3.2. Immunotherapy

            7.3.2.1. Subcutaneous Immunotherapy (SCIT)

            7.3.2.2. Sublingual Immunotherapy (SLIT)

    7.4. Market Attractiveness Analysis, by Treatment

8. Global Allergy Treatment Market Analysis and Forecast, by Distribution Channel

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by Distribution Channel, 2020-2034

        8.3.1. Hospital Pharmacies

        8.3.2. Retail Pharmacies & Drug Stores

        8.3.3. Online Pharmacies

    8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Allergy Treatment Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region, 2020-2034

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Allergy Treatment Market Analysis and Forecast

    10.1. Introduction

    10.2. Key Findings

    10.3. Market Value Forecast, by Allergy Type, 2020-2034

        10.3.1. Food Allergy

        10.3.2. Inhaled Allergy

        10.3.3. Drug Allergy

        10.3.4. Others

    10.4. Market Value Forecast, by Treatment, 2020-2034

        10.4.1. Anti-allergy Drugs

            10.4.1.1. Antihistamines

            10.4.1.2. Corticosteroids

            10.4.1.3. Leukotriene Inhibitors

            10.4.1.4. Others

        10.4.2. Immunotherapy

            10.4.2.1. Subcutaneous Immunotherapy (SCIT)

            10.4.2.2. Sublingual Immunotherapy (SLIT)

    10.5. Market Value Forecast, by Distribution Channel, 2020-2034

        10.5.1. Hospital Pharmacies

        10.5.2. Retail Pharmacies & Drug Stores

        10.5.3. Online Pharmacies

    10.6. Market Value Forecast, by Country, 2020-2034

        10.6.1. U.S.

        10.6.2. Canada

    10.7. Market Attractiveness Analysis

        10.7.1. By Allergy Type

        10.7.2. By Treatment

        10.7.3. By Distribution Channel

        10.7.4. By Country

11. Europe Allergy Treatment Market Analysis and Forecast

    11.1. Introduction

    11.2. Key Findings

    11.3. Market Value Forecast, by Allergy Type, 2020-2034

        11.3.1. Food Allergy

        11.3.2. Inhaled Allergy

        11.3.3. Drug Allergy

        11.3.4. Others

    11.4. Market Value Forecast, by Treatment, 2020-2034

        11.4.1. Anti-allergy Drugs

            11.4.1.1. Antihistamines

            11.4.1.2. Corticosteroids

            11.4.1.3. Leukotriene Inhibitors

            11.4.1.4. Others

        11.4.2. Immunotherapy

            11.4.2.1. Subcutaneous Immunotherapy (SCIT)

            11.4.2.2. Sublingual Immunotherapy (SLIT)

    11.5. Market Value Forecast, by Distribution Channel, 2020-2034

        11.5.1. Hospital Pharmacies

        11.5.2. Retail Pharmacies & Drug Stores

        11.5.3. Online Pharmacies

    11.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        11.6.1. Germany

        11.6.2. U.K.

        11.6.3. France

        11.6.4. Italy

        11.6.5. Spain

        11.6.6. Rest of Europe

    11.7. Market Attractiveness Analysis

        11.7.1. By Allergy Type

        11.7.2. By Treatment

        11.7.3. By Distribution Channel

        11.7.4. By Country/Sub-region

12. Asia Pacific Allergy Treatment Market Analysis and Forecast

    12.1. Introduction

    12.2. Key Findings

    12.3. Market Value Forecast, by Allergy Type, 2020-2034

        12.3.1. Food Allergy

        12.3.2. Inhaled Allergy

        12.3.3. Drug Allergy

        12.3.4. Others

    12.4. Market Value Forecast, by Treatment, 2020-2034

        12.4.1. Anti-allergy Drugs

            12.4.1.1. Antihistamines

            12.4.1.2. Corticosteroids

            12.4.1.3. Leukotriene Inhibitors

            12.4.1.4. Others

        12.4.2. Immunotherapy

            12.4.2.1. Subcutaneous Immunotherapy (SCIT)

            12.4.2.2. Sublingual Immunotherapy (SLIT)

    12.5. Market Value Forecast, by Distribution Channel, 2020-2034

        12.5.1. Hospital Pharmacies

        12.5.2. Retail Pharmacies & Drug Stores

        12.5.3. Online Pharmacies

    12.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        12.6.1. China

        12.6.2. Japan

        12.6.3. India

        12.6.4. Australia & New Zealand

        12.6.5. Rest of Asia Pacific

    12.7. Market Attractiveness Analysis

        12.7.1. By Allergy Type

        12.7.2. By Treatment

        12.7.3. By Distribution Channel

        12.7.4. By Country/Sub-region

13. Latin America Allergy Treatment Market Analysis and Forecast

    13.1. Introduction

    13.2. Key Findings

    13.3. Market Value Forecast, by Allergy Type, 2020-2034

        13.3.1. Food Allergy

        13.3.2. Inhaled Allergy

        13.3.3. Drug Allergy

        13.3.4. Others

    13.4. Market Value Forecast, by Treatment, 2020-2034

        13.4.1. Anti-allergy Drugs

            13.4.1.1. Antihistamines

            13.4.1.2. Corticosteroids

            13.4.1.3. Leukotriene Inhibitors

            13.4.1.4. Others

        13.4.2. Immunotherapy

            13.4.2.1. Subcutaneous Immunotherapy (SCIT)

            13.4.2.2. Sublingual Immunotherapy (SLIT)

    13.5. Market Value Forecast, by Distribution Channel, 2020-2034

        13.5.1. Hospital Pharmacies

        13.5.2. Retail Pharmacies & Drug Stores

        13.5.3. Online Pharmacies

    13.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        13.6.1. Brazil

        13.6.2. Mexico

        13.6.3. Rest of Latin America

    13.7. Market Attractiveness Analysis

        13.7.1. By Allergy Type

        13.7.2. By Treatment

        13.7.3. By Distribution Channel

        13.7.4. By Country/Sub-region

14. Middle East & Africa Allergy Treatment Market Analysis and Forecast

    14.1. Introduction

    14.2. Key Findings

    14.3. Market Value Forecast, by Allergy Type, 2020-2034

        14.3.1. Food Allergy

        14.3.2. Inhaled Allergy

        14.3.3. Drug Allergy

        14.3.4. Others

    14.4. Market Value Forecast, by Treatment, 2020-2034

        14.4.1. Anti-allergy Drugs

            14.4.1.1. Antihistamines

            14.4.1.2. Corticosteroids

            14.4.1.3. Leukotriene Inhibitors

            14.4.1.4. Others

        14.4.2. Immunotherapy

            14.4.2.1. Subcutaneous Immunotherapy (SCIT)

            14.4.2.2. Sublingual Immunotherapy (SLIT)

    14.5. Market Value Forecast, by Distribution Channel, 2020-2034

        14.5.1. Hospital Pharmacies

        14.5.2. Retail Pharmacies & Drug Stores

        14.5.3. Online Pharmacies

    14.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        14.6.1. GCC Countries

        14.6.2. South Africa

        14.6.3. Rest of Middle East & Africa

    14.7. Market Attractiveness Analysis

        14.7.1. By Allergy Type

        14.7.2. By Treatment

        14.7.3. By Distribution Channel

        14.7.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

    15.2. Market Share Analysis, by Company (2023)

    15.3. Company Profiles

        15.3.1. ALK

            15.3.1.1. Company Overview

            15.3.1.2. Product Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Financial Overview

            15.3.1.5. Strategic Overview

        15.3.2. Stallergenes Greer

            15.3.2.1. Company Overview

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Financial Overview

            15.3.2.5. Strategic Overview

        15.3.3. Allergy Therapeutics

            15.3.3.1. Company Overview

            15.3.3.2. Product Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Financial Overview

            15.3.3.5. Strategic Overview

        15.3.4. HAL Allergy B.V.

            15.3.4.1. Company Overview

            15.3.4.2. Product Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Financial Overview

            15.3.4.5. Strategic Overview

        15.3.5. GSK

            15.3.5.1. Company Overview

            15.3.5.2. Product Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Financial Overview

            15.3.5.5. Strategic Overview

        15.3.6. Sunovion Pharmaceuticals, Inc.

            15.3.6.1. Company Overview

            15.3.6.2. Product Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Financial Overview

            15.3.6.5. Strategic Overview

        15.3.7. Teva Pharmaceutical Industries Ltd.

            15.3.7.1. Company Overview

            15.3.7.2. Product Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Financial Overview

            15.3.7.5. Strategic Overview

        15.3.8. AbbVie Inc.

            15.3.8.1. Company Overview

            15.3.8.2. Product Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Financial Overview

            15.3.8.5. Strategic Overview

        15.3.9. Thermo Fisher Scientific, Inc.

            15.3.9.1. Company Overview

            15.3.9.2. Product Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Financial Overview

            15.3.9.5. Strategic Overview

        15.3.10. Meda AB

            15.3.10.1. Company Overview

            15.3.10.2. Product Portfolio

            15.3.10.3. SWOT Analysis

            15.3.10.4. Financial Overview

            15.3.10.5. Strategic Overview

List of Tables

Table 01: Global Allergy Treatment Market Size (US$ Mn) Forecast, by Allergy Type, 2020-2034

Table 02: Global Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment, 2020-2034

Table 03: Global Allergy Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 04: Global Allergy Treatment Market Size (US$ Mn) Forecast, by Region, 2020-2034

Table 05: North America Allergy Treatment Market Size (US$ Mn) Forecast, by Country, 2020-2034

Table 06: North America Allergy Treatment Market Size (US$ Mn) Forecast, by Allergy Type, 2020-2034

Table 07: North America Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment, 2020-2034

Table 08: North America Allergy Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 09: Europe Allergy Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 10: Europe Allergy Treatment Market Size (US$ Mn) Forecast, by Allergy Type, 2020-2034

Table 11: Europe Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment, 2020-2034

Table 12: Europe Allergy Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 13: Asia Pacific Allergy Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Asia Pacific Allergy Treatment Market Size (US$ Mn) Forecast, by Allergy Type, 2020-2034

Table 15: Asia Pacific Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment, 2020-2034

Table 16: Asia Pacific Allergy Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 17: Latin America Allergy Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 18: Latin America Allergy Treatment Market Size (US$ Mn) Forecast, by Allergy Type, 2020-2034

Table 19: Latin America Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment, 2020-2034

Table 20: Latin America Allergy Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 21: Middle East & Africa Allergy Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Middle East & Africa Allergy Treatment Market Size (US$ Mn) Forecast, by Allergy Type, 2020-2034

Table 23: Middle East & Africa Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment, 2020-2034

Table 24: Middle East & Africa Allergy Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

Figure 01: Global Allergy Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034

Figure 02: Global Allergy Treatment Market Revenue (US$ Mn), by Allergy Type, 2023

Figure 03: Global Allergy Treatment Market Value Share, by Allergy Type, 2023

Figure 04: Global Allergy Treatment Market Revenue (US$ Mn), by Treatment, 2023

Figure 05: Global Allergy Treatment Market Value Share, by Treatment, 2023

Figure 06: Global Allergy Treatment Market Revenue (US$ Mn), by Distribution Channel, 2023

Figure 07: Global Allergy Treatment Market Value Share, by Distribution Channel, 2023

Figure 08: Global Allergy Treatment Market Value Share, by Region, 2023

Figure 09: Global Allergy Treatment Market Value (US$ Mn) Forecast, 2020-2034

Figure 10: Global Allergy Treatment Market Value Share Analysis, by Allergy Type, 2023 and 2034

Figure 11: Global Allergy Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 12: Global Allergy Treatment Market Value Share Analysis, by Treatment, 2023 and 2034

Figure 13: Global Allergy Treatment Market Attractiveness Analysis, by Treatment, 2024-2034

Figure 14: Allergy Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 15: Global Allergy Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 16: Global Allergy Treatment Market Value Share Analysis, by Region, 2023 and 2034

Figure 17: Global Allergy Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 18: North America Allergy Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 19: North America Allergy Treatment Market Attractiveness Analysis, by Country, 2024-2034

Figure 20: North America Allergy Treatment Market Value Share Analysis, by Country, 2023 and 2034

Figure 21: North America Allergy Treatment Market Value Share Analysis, by Allergy Type, 2023 and 2034

Figure 22: North America Allergy Treatment Market Value Share Analysis, by Treatment, 2023 and 2034

Figure 23: North America Allergy Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 24: North America Allergy Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 25: North America Allergy Treatment Market Attractiveness Analysis, by Treatment, 2024-2034

Figure 26: North America Allergy Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 27: Europe Allergy Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 28: Europe Allergy Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 29: Europe Allergy Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 30: Europe Allergy Treatment Market Value Share Analysis, by Allergy Type, 2023 and 2034

Figure 31: Europe Allergy Treatment Market Value Share Analysis, by Treatment, 2023 and 2034

Figure 32: Europe Allergy Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 33: Europe Allergy Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 34: Europe Allergy Treatment Market Attractiveness Analysis, by Treatment, 2024-2034

Figure 35: Europe Allergy Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 36: Asia Pacific Allergy Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 37: Asia Pacific Allergy Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 38: Asia Pacific Allergy Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 39: Asia Pacific Allergy Treatment Market Value Share Analysis, by Allergy Type, 2023 and 2034

Figure 40: Asia Pacific Allergy Treatment Market Value Share Analysis, by Treatment, 2023 and 2034

Figure 41: Asia Pacific Allergy Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 42: Asia Pacific Allergy Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 43: Asia Pacific Allergy Treatment Market Attractiveness Analysis, by Treatment, 2024-2034

Figure 44: Asia Pacific Allergy Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 45: Latin America Allergy Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 46: Latin America Allergy Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 47: Latin America Allergy Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 48: Latin America Allergy Treatment Market Value Share Analysis, by Allergy Type, 2023 and 2034

Figure 49: Latin America Allergy Treatment Market Value Share Analysis, by Treatment, 2023 and 2034

Figure 50: Latin America Allergy Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 51: Latin America Allergy Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 52: Latin America Allergy Treatment Market Attractiveness Analysis, by Treatment, 2024-2034

Figure 53: Latin America Allergy Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 54: Middle East & Africa Allergy Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 55: Middle East & Africa Allergy Treatment Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 56: Middle East & Africa Allergy Treatment Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 57: Middle East & Africa Allergy Treatment Market Value Share Analysis, by Allergy Type, 2023 and 2034

Figure 58: Middle East & Africa Allergy Treatment Market Value Share Analysis, by Treatment, 2023 and 2034

Figure 59: Middle East & Africa Allergy Treatment Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 60: Middle East & Africa Allergy Treatment Market Attractiveness Analysis, by Region, 2024-2034

Figure 61: Middle East & Africa Allergy Treatment Market Attractiveness Analysis, by Treatment, 2024-2034

Figure 62: Middle East & Africa Allergy Treatment Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Copyright © Transparency Market Research, Inc. All Rights reserved